healthcare · MAXHEALTH
Max Healthcare
Max Healthcare: PE below historical average. NARROW LEADERSHIP regime.
Price
₹1,124.8
Price 2026-07-30
5 day
+4.11%
Short-term move
1 month
-0.22%
Medium-term
Regime
NARROW LEADERSHIP
62% confidence
Market cap
₹108.8k Cr
neutral sector flow
Market Intelligence Analyst
Understand today's market in about 2 minutes.
“How does today's NARROW LEADERSHIP regime affect Max Healthcare (MAXHEALTH) in the healthcare sector?”
Price chart
₹1,105
-13.32% over period
About Max Healthcare
Max Healthcare Institute Limited provides medical and healthcare services in India. It offers services in various specialties, including cardiac sciences, orthopedics, oncology, renal sciences, neurosciences, minimal access and general surgery, pulmonology, obstetrics, gynecology, pediatrics, and nephrology, liver and biliary sciences, gastroenterology and Gi surgery, Internal Medicine, plastic and reconstructive surgery, and organ transplants, as well as ear, nose, and throat. The company also provides Max@Home, a platform that offers health and wellness services at home; and MaxLab, which provides diagnostic testing services to patients. In addition, it provides organ and tissue donation, preventive health checks, ambulance services, immigration services, air ambulance, and insurance and TPA services. The company operates through a network of healthcare facilities, including hospitals and medical centres. The company was incorporated in 2001 and is based in Gurugram, India.
At a Glance
RSI pattern warning
RSI oversold bounces for this stock succeeded only 0% of the time (avg -8.5% over 14 days) — not a reliable pattern.
52-week position
Trading at 85.8% of 52-week high
Technicals
RSI 14
55.9
Trend
uptrend
50 DMA
Above
200 DMA
Above
Key metrics
P/E ratio
76.0
29th pct · 7 quarterly points (limited history)
P/B
10.1
ROE
14.3%
Moderate profitability — 14.3% ROE
Market cap
₹108.8k Cr
Revenue growth
1220.0% YoY
Promoter
27.1%
52-week range
₹903 – ₹1,310.8
85.8% of high
RSI (14)
55.9
uptrend
vs 50 DMA
Above
DMA ₹1,069.09
Fundamental
85/100
STRONG
Trust
95/100
Verification
Coverage
100/100
HIGH
Quick Take
Max Healthcare scores 85/100 on fundamentals (strong). Max Healthcare: PE below historical average. NARROW LEADERSHIP regime.
Fundamental Score: 85/100 · STRONG · 0 signals detected
DuPont Analysis
ROE 13.4% broken into three drivers. Each shows how efficiently the company generates returns.
ROE of 13.43% is moderate margin-driven and stable. Net margin 17.2%, asset turnover 0.49x, leverage 1.6x.
What This Means
Net margin of 17.2% means the company keeps ₹17.2 as profit for every ₹100 of revenue. This is a healthy margin. Asset turnover of 0.49x means the company generates ₹0.49 of revenue for every ₹1 of assets. This is a capital-heavy business. Leverage of 1.6x means the company uses moderate debt. Returns are primarily driven by operations, not borrowing.
Margin Structure
Gross
78.6%
Operating
22.8%
Net
17.2%
Gross margin 78.6% → operating margin 22.8% → net margin 17.2%. Margins are IMPROVING. Strong pricing power with stable gross margins suggests the improvement is from operating leverage — sustainable.
Financial Health
Earnings Quality
ADEQUATECash flow covers net income 1.1x — earnings are ADEQUATE quality. Cash conversion is reasonable.
Debt Sustainability
COMFORTABLEInterest covered 8.1x — very comfortable. Debt service is not a concern. Debt/EBITDA at 1.5x is low — balance sheet has capacity.
Free Cash Flow
MODERATEFCF margin at 1.8% — barely positive. Limited cash after capex.
Peer comparison
| Stock | Price | 5D | P/E | ROE | Rev growth | Mcap |
|---|---|---|---|---|---|---|
| APOLLOHOSP Apollo Hospitals | ₹8,988 | +1.4% | 65.4 | 21.5% | 1810% | ₹1.3L Cr |
| FORTIS Fortis Healthcare | ₹948.85 | +0.7% | 70.3 | 11% | 1780% | ₹73.4k Cr |
| ASTERDM Aster DM Healthcare | ₹814 | +3.8% | 104.9 | 10.1% | 1820% | ₹40.8k Cr |
| NH Narayana Hrudayalaya | ₹2,080.3 | +4.9% | 50.2 | 19.8% | 7580% | ₹40.7k Cr |
| LALPATHLAB Dr. Lal Pathlabs | ₹1,878.8 | +11.7% | 55.7 | 21.5% | 1660% | ₹28.1k Cr |
| MAXHEALTH Max Healthcare | ₹1,124.8 | +3.7% | 76 | 14.3% | 1220% | ₹1.1L Cr |
Tensions to watch
PE in bottom 29% historically — undervaluation or fundamental deterioration?
Low PE can signal value OR declining growth expectations. Check recent earnings and sector outlook.
Key Watchpoints
Breaks above ₹1181 (+5%)
Trend reversal confirmation
Breaks below ₹1069 (-5%)
Further downside risk
PE reverts to median of 78.1 (7 quarterly points (limited history))
Valuation normalization
Healthcare sector entering leadership
Sector rotation signal
Risk Flags
Tight liquidity. Monitor cash position and access to credit lines.
High revenue multiple. Market pricing in significant growth or margins expansion.
Modern asset base. Lower near-term capex requirements.
➡️ 3 flags — 1 positive, 2 warning. Mixed profile.
Data Quality
News Correlation
50 articles scanned for fundamental themes
